Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

   

Three Months Ended

June 30,

   

Six Months Ended

June 30,

 
    2021     2020     2021     2020  
Options to purchase common stock     1,448,193       1,060,254       1,448,193       1,060,254  
Restricted Stock Unvested     520,167       -       520,167       -  
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO Merger common stock purchase warrants and post-merger AYRO warrants issued     7,346,447       4,006,205       7,346,447       4,006,205  
Series H, H-3, H-6, and pre-merger AYRO Seed Preferred Stock     2,475       278,862       2,475       278,862  
Totals     9,317,282       5,345,321       9,317,282       5,345,321